Rating and Comparison of Well-known Cardiovascular Risk Factors in Kermanian Male Patients Using Fuzzy Linear Regression

Document Type : Original Article

Authors

1 Modeling in Health Research Center, Institute for Futures Studies in Health & Department of Biostatistics and Epidemiology, Faculty of Health, Kerman university of Medical Sciences, Kerman, Iran

2 Assistant Professor, Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

3 Department of Cardiology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

4 Professor of Biostatistics, Modeling in Health Research Center, Institute for Futures Studies in Health & Department of Biostatistics and Epidemiology, Faculty of Health, Kerman university of Medical Sciences, Kerman, Iran 5-Adjunct Professor of Griffith University, Brisbane, QLD, Australia. (

Abstract

Background:Cardiovascular diseases are still among the most important causes of death in different countries. There are several risk factors for the onset of this disease. The rating of these risk factors is very important for informing the community and planning for the future.
Methods: Linear regression is one of the classic statistical methods that has many applications in medical sciences. When dealing with fuzzy data, it is not possible to use linear regression. The use of angiography to estimate the extent of congestion is associated with an estimate of more or less stenosis and the increase of atherosclerosis. Hence, this variable has been considered as a fuzzy variable. Fuzzy linear regression (FLR) was used to rank and compare the known risk factors for coronary artery occlusion.
Results:After analyzing the data by least squares FLR, the most important risk factors included Family history, history of diabetes, age, history of hypercholesterolemia, history of cigarette smoking, Body Mass Index and history of hypertension respectively.
Conclusion: When it is not possible to calculate the response variable or one of the independent variables examined in the model accurately, FLR, or to be more precise, regression in fuzzy environment can be a good alternative for conventional regression analysis.

Keywords

References

  1. WHO. Cardiovascular diseases. [cited 2021 Feb 12] Available from: https://www.who.int/health-topics/cardiovascular-diseases/#tab=tab_1.
  2. WHO. Cardiovascular diseases (CVDs). [cited 2021 Feb 12] Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
  3. Saadat S, Yousefifard M, Asady H, Moghadas Jafari A, Fayaz M, Hosseini M. The most important causes of death in Iranian population; a retrospective cohort study. Emerg (Tehran) 2015; 3(1):16-21.
  4. Sadeghi M, Haghdoost AA, Bahrampour A, Dehghani M. Modeling the burden of cardiovascular diseases in Iran from 2005 to 2025: the impact of demographic changes. Iranian Journal of Public Health 2017; 46(4):506-16.
  5. Sarrafzadegan N, Mohammmadifard N. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med 2019; 22(4):204-10.
  6. Bots SH, Peters SA, Woodward M. Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010. BMJ Glob Health 2017; 2(2):e000298.
  7. Carter HE, Schofield D, Shrestha R. Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups. Open Heart 2019; 6(1):e000939.
  8. Zdrenghea D, Guşetu G, Zdrenghea M, Cismaru G, Caloian B, Vaidean G, et al. CV RISK–A new relative cardiovascular risk score. Medical Hypotheses 2019; 132:109362.
  9. Zhang Y, Cong H, Man C, Su Y, Sun H, Yang H, et al. Risk factors for cardiovascular disease from a population-based screening study in Tianjin, China: a cohort study of 36,215 residents. Ann Transl Med 2020; 8(7):444.
  10. Psaltopoulou T, Hatzis G, Papageorgiou N, Androulakis E, Briasoulis A, Tousoulis D. Socioeconomic status and risk factors for cardiovascular disease: impact of dietary mediators. Hellenic J Cardiol 2017; 58(1):32-42.
  11. Rampidis GP, Benetos G, Benz DC, Giannopoulos AA, Buechel RR. A guide for gensini score calculation. Atherosclerosis 2019; 287:181-3.
  12. Neeland IJ, Patel RS, Eshtehardi P, Dhawan S, McDaniel MC, Rab ST, et al. Coronary angiographic scoring systems: an evaluation of their equivalence and validity. Am Heart J 2012; 164(4):547-52.
  13. Tanaka H. Fuzzy data analysis by possibilistic linear models. Fuzzy Sets and Systems 1987; 24(3):363-75.
  14. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007; 165(6):710-8.
  15. Scheuner MT, Whitworth WC, McGruder H, Yoon PW, Khoury MJ. Expanding the definition of a positive family history for early-onset coronary heart disease. Genet Med 2006; 8(8):491-501.
  16. D'Urso P, Gastaldi T. A least-squares approach to fuzzy linear regression analysis. Computational Statistics & Data Analysis 2000; 34(4):427-40.
  17. Shapiro AF. Fuzzy regression models. Article of Penn State University 2005; 102(2):373-83.
  18. Ross TJ. Fuzzy Logic with Engineering Applications. 3th ed. UK: Wiley; 2010. p. 89-111.
  19. Sadeghpour Gildeh B, Gine D. A goodness of fit index to reliability analysis in fuzzy model. [cited 2020 Oct 11] Available from: http://www.wseas.us/e-library/conferences/switzerland2002/papers/391.pdf.
  20. Chacko M, Sarma PS, Harikrishnan S, Zachariah G, Jeemon P. Family history of cardiovascular disease and risk of premature coronary heart disease: a matched case-control study. Wellcome Open Res 2020; 5:70.
  21. Hudspeth B. The burden of cardiovascular disease in patients with diabetes. Am J Manag Care 2018; 24(13 Suppl):S268-S72.
  22. Gong FF, Coller JM, McGrady M, Boffa U, Shiel L, Liew D, et al. Age‐related longitudinal change in cardiac structure and function in adults at increased cardiovascular risk. ESC Heart Fail 2020; 7(3):1344-61
  23. Huffman MD, Berry JD, Ning H, Dyer AR, Garside DB, Cai X, et al. Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project. J Am Coll Cardiol 2013; 61(14):1510-7.
  24. Khoramdad M, Vahedian‐azimi A, Karimi L, Rahimi‐Bashar F, Amini H, Sahebkar AJIl. Association between passive smoking and cardiovascular disease: a systematic review and meta‐analysis. IUBMB Life 2020; 72(4):677-86.
  25. Formentini FS, Nagano FE, Neto FD, Adam EL, Fortes FS, da Silva LF. Coronary artery disease and body mass index: What is the relationship? Clinical Nutrition ESPEN 2019; 34:87-93.
  26. Jazayeri MA, Waheed S, Shah Z, Parashara D, Gupta K. Impact of body mass index on the association of ankle-brachial index with all-cause and cardiovascular mortality: results from the national health and nutrition examination survey. Mayo Clin Proc Innov Qual Outcomes 2019; 3(4):409-17.
  27. Tackling G, Borhade MB. Hypertensive heart disease. [cited 2021 Feb 28] Available from: https://www.ncbi.nlm.nih.gov/books/NBK539800/.
  28. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects), Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1 8 million participants. Lancet 2014; 383(9921):970-83.
  29. Tzoulaki I, Elliott P, Kontis V, Ezzati MJC. Worldwide exposures to cardiovascular risk factors and associated health effects: current knowledge and data gaps. Circulation 2016; 133(23):2314-33.

 

 

Journal of Kerman University of Medical Sciences
Volume 28, Issue 2
March and April 2021
Pages 150-156

Files

Share

How to cite

Statistics